|Yasuhiro Maruoka||Last modified date：2019.07.01|
I major in nuclear medicine and provide different kinds of medical services or research programs (radioiodine therapy, nuclear cardiology, SPECT/CT, PET/CT, PET/MRI and so on). .
Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Field of Specialization
Engagement in the medical care, research, education, and social activities on nuclear medicine at Kyushu University Hospital
Research InterestsMembership in Academic Society
- 131I therapy for differentiated thyroid carcinoma
keyword : Differentiated thyroid carcinoma, 131I therapy
|1.||Usefulness of Salivary Gland Scintigraphy after Initial 131I Therapy for Differentiated Thyroid Carcinoma: Association with Salivary Gland Dysfunction after Continued Therapy.|
- The Japanese Society of Nuclear Medicine
- The Japanese Board of Radiology